Federal Register · Regulatory notice
United States, et al. v. OhioHealth Corporation; Amended Response to Public Comments on the Proposed Final Judgment
A Notice notice explicitly mentions the company. Read the cited text for its role.
Follow MSFT- Became public
- Nov 5, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 5:57 PM EST
Why this is connected
The source explicitly mentions MICROSOFT CORP. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
y of such judgment upon competition in the relevant market or markets, upon the public generally and individuals alleging specific injury from the violations set forth in the complaint including consideration of the public benefit, if any, to be derived from a determination of the issues at trial. 15 U.S.C. 16(e)(1)(A) & (B). In considering these statutory factors, the Court's inquiry is necessarily a limited one, as the government is entitled to ``broad discretion to settle with the defendant within the reaches of the public interest.'' United States v. Microsoft Corp., 56 F.3d 1448, 1461 (D.C. Cir. 1995); United States v. Hewlett Packard Enter. Co., No. 25- CV-00951-PCP, 2026 WL 2349970, at *16 (N.D. Cal. Aug. 12, 2026); United States v. U.S. Airways Grp., Inc., 38 F. Supp. 3d 69, 75 (D.D.C. 2014) (explaining that the ``court's inquiry is limited'' in Tunney Act settlements); United States v. InBev N.V./S.A., No. 08-1965 (JR), 2009 U.S. Dist. LEXIS 84787, at *3 (D.D.C. Aug. 11, 2009) (noting that a court's review of a proposed final judgment is limited and only inquires ``into whether the government's determination that the proposed remedies will cure the antitrust violations alleged in the complaint [is] reasonable, and whether the mechanisms to enforce the final judgment are clear and manageable''); United States v. Charleston Area Med. Ctr., Inc., No. 2:16-3664, 2016 U.S.
Congressional trading in MSFT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 4, 2026$1K–$15K
Sen. Shelley Moore Capito (R-WV)
$1K–$15K · Traded Oct 21, 2026 · disclosed Nov 4, 2026 · Spouse
Traded 7 days before earningsGot $11K from the company’s PAC - Nov 2, 2026$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
$1K–$15K · Traded Oct 15, 2026 · disclosed Nov 2, 2026 · Spouse
Traded 13 days before earnings - Oct 27, 2026$250K–$500K
Rep. Pete Sessions (R-TX-17)
$250K–$500K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 12, 2026 · Spouse
Got $30K from the company’s PAC - Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 2, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
$1K–$15K · Traded Sep 28, 2026 · disclosed Oct 2, 2026
- Oct 1, 2026$1K–$15K
Rep. Cleo Fields (D-LA-6)
$1K–$15K · Traded Sep 10, 2026 · disclosed Oct 1, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.